Literature DB >> 10971036

Enhancement of toluidine blue staining by transforming growth factor-beta, insulin-like growth factor and growth hormone in the temporomandibular joint of aged mice.

I Blumenfeld1, R Gaspar, D Laufer, E Livne.   

Abstract

Osteoarthritic lesions appear in the articular cartilage of the temporomandibular joint of mice aged 7 months and older. Reduced rate of proteoglycan (PG) synthesis leading to destruction of the articular cartilage was observed in this joint. The purpose of the present study was to test the ability of transforming growth factor-beta1 (TGF-beta1), insulin-like growth factor-1 (IGF-1) and growth hormone (GH) to induce PG synthesis in joint cartilage of aged animals and to compare it with the effect of interleukin-1alpha (IL-1alpha). Mandibular condyle explants from 18-month-old mice were cultured up to 72 h in serum-free medium, supplemented with IL-1alpha (TGF-beta1 (0.1-5.0 ng/ml), TGF-beta1 (1.0 ng/ml) + IGF-1 (2 ng/ml) or GH (10 ng/ml). The incorporation of (35)S-SO(4) into sulfated PG was tested. Cartilage samples were processed for histomorphometry using sections stained with 0.1% toluidine blue (TB), pH 1.8. Results indicated that in cultures supplemented (48 h) with either TGF-beta, TGF-beta + IGF-1 or with GH, an increased height and area of TB-positive staining as well as increased incorporation of (35)S-SO(4) into sulfated PG were observed. In contrast, the cytokine IL-1alpha exerted an inhibitory effect on TB staining and on (35)S-SO(4) incorporation. The present study demonstrated that in vitro supplementation of IL-1alpha to mandibular condyle cartilage reduced the height and area of TB staining and incorporation of (35)S-SO(4), whereas TGF-beta1, TGF-beta1 + IGF-1 or GH increased the height and area of TB staining and increased incorporation of (35)S-SO(4). The two parameters used to identify increased PG synthesis were shown to reveal similar results and were useful for studying the dynamic events taking place in cartilage destruction and repair in osteoarthritis. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971036     DOI: 10.1159/000016775

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  6 in total

Review 1.  Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering.

Authors:  Eduardo K Moioli; Paul A Clark; Xuejun Xin; Shan Lal; Jeremy J Mao
Journal:  Adv Drug Deliv Rev       Date:  2007-04-18       Impact factor: 15.470

2.  Genetic expression of MMP-Matrix-mettalo-proteinases (MMP-1 and MMP-13) as a function of anterior mandibular repositioning appliance on the growth of mandibular condylar cartilage with and without administration of Insulin like growth factor (IGF-1) and Transforming growth factor-B (TGF-β).

Authors:  Amol Patil; Ravindranath Sable; Ramanlal Kothari
Journal:  Angle Orthod       Date:  2012-03-22       Impact factor: 2.079

Review 3.  Effects of GH/IGF axis on bone and cartilage.

Authors:  Manisha Dixit; Sher Bahadur Poudel; Shoshana Yakar
Journal:  Mol Cell Endocrinol       Date:  2020-10-14       Impact factor: 4.102

4.  Morphological and histopathological changes in orofacial structures of experimentally developed acromegaly-like rats: an overview.

Authors:  Masahiro Iikubo; Ikuho Kojima; Maya Sakamoto; Akane Kobayashi; Hidetoshi Ikeda; Takashi Sasano
Journal:  Int J Endocrinol       Date:  2012-02-28       Impact factor: 3.257

5.  PDGF is a potent initiator of bone formation in a tissue engineered model of pathological ossification.

Authors:  Owen G Davies; Liam M Grover; Mark P Lewis; Yang Liu
Journal:  J Tissue Eng Regen Med       Date:  2017-03-20       Impact factor: 3.963

6.  Carbonic Anhydrase 12 Protects Endplate Cartilage From Degeneration Regulated by IGF-1/PI3K/CREB Signaling Pathway.

Authors:  Xing Zhao; Panyang Shen; Haidong Li; Yute Yang; Jiandong Guo; Shuai Chen; Yan Ma; Jiamin Sheng; Shuying Shen; Gang Liu; Xiangqian Fang
Journal:  Front Cell Dev Biol       Date:  2020-10-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.